Indaptus Therapeutics, Inc.

INDPNASDAQ Capital Market·USD·Closed

INDPNASDAQ·USD·Closed

$1.29

−10.42%

$1.29

−$0.15 (10.42%)

52W Range

5thpctl

Volume

0.09×avg

Mkt Cap

2.26MUSD

P/E

-0.2TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

5thpctl

Volume

0.09×avg

Market Cap

2.26MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-1396.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio2.34×